NDAINTRAVITREALIMPLANT
Approved
Oct 2018
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
17
Data completeness
5/8 — Partial
YUTIQ (fluocinolone acetonide) by Eurofarma Laboratórios is corticosteroid hormone receptor agonists [moa]. First approved in 2018.
Drug data last refreshed 4h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
YUTIQ is a fluocinolone acetonide intravitreal implant approved in 2018 for sustained corticosteroid delivery to the back of the eye. It works as a corticosteroid hormone receptor agonist to reduce inflammation in ocular conditions. The implant formulation enables long-acting therapeutic effect with reduced dosing frequency compared to topical or systemic alternatives.
$0.2MPart D
LOE Approaching1.6 years to LOENiche ophthalmology product with minimal Medicare Part D penetration (17 claims in 2023) approaching loss of exclusivity, suggesting small commercial team and limited growth trajectory.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (17)
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
Started Nov 2023
600 enrolled
Radiation RetinopathyVisual Impairment
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
Started Oct 2022
30 enrolled
UveitisUveitis, PosteriorUveitis, Anterior+1 more
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
Started Jun 2022
125 enrolled
Uveitis, Posterior
Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant
Started Jul 2017
3 enrolled
Uveitis, Posterior
Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant
Started Feb 2016
98 enrolled
InflammationUveitis
Worked on YUTIQ at Eurofarma Laboratórios? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.